cervical cancer

Daily

Startup’s antiviral drug combats HPV, new study shows

San Diego startup Hera Therapeutics is developing a topical antiviral drug that attacks human papillomavirus – and early studies are showing it can successfully combat three strains, including two that cause 70 percent of all cervical cancer. The drug candidate, HTI-1968, blocked the replication of HPV-16, HPV-18 and HPV-11 cells, according to the NIAID-sponsored study. The work […]

presented by